| Emily J Campbell, PHD | |
|
2601 Airport Dr Ste 135, Torrance, CA 90505-6141 | |
| (424) 201-1600 | |
| Not Available |
| Full Name | Emily J Campbell |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 2601 Airport Dr Ste 135, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063130714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily J Campbell, PHD Po Box 4678, Auburn, CA 95604-4678 Ph: (530) 305-9155 | Emily J Campbell, PHD 2601 Airport Dr Ste 135, Torrance, CA 90505-6141 Ph: (424) 201-1600 |
News Archive
A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.
Irritable bowel syndrome patients extensively suffer from chronic visceral hypersensitivity, with involvement of all levels of the brain-gut axis, as well as various neurotransmitters.
University of Alabama at Birmingham School of Nursing Assistant Professor Loretta T. Lee, Ph.D., has received a 2015 Deep South Resource Center for Minority Aging pilot grant award to examine the association of social support and intuitive eating with glycemic control in older African-American men with diagnosed type 2 diabetes.
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.
› Verified 2 days ago
Emily P. Chen, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2601 Airport Dr Ste 135, Torrance, CA 90505 Phone: 424-201-1600 Fax: 424-201-1601 | |
Mrs. Megan Kay Higinbotham, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 25550 Hawthorne Blvd Ste 316, Torrance, CA 90505 Phone: 424-757-4344 | |
Stanley Chow, M.A. Psychologist Medicare: Medicare Enrolled Practice Location: 2325 Crenshaw Blvd, Icat/dmh, Torrance, CA 90501 Phone: 310-972-3337 | |
Dr. Nourit H Korzennik, PH D Psychologist Medicare: Medicare Enrolled Practice Location: 24050 Madison St, Suite 100-c, Torrance, CA 90505 Phone: 310-378-7333 | |
Dale Stuart, PH.D., SC.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3510 Torrance Blvd, Suite 100, Torrance, CA 90503 Phone: 310-371-3543 | |
Miss Erin Shea Linn, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4025 W 226th St, Torrance, CA 90505 Phone: 310-373-4556 | |
Dr. Jessica Lee, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3838 W Carson St, Suite 333, Torrance, CA 90503 Phone: 310-560-9335 |